CN1288748A - Medicine for treating cardiac and cerebral vascular diseases and its preparation - Google Patents
Medicine for treating cardiac and cerebral vascular diseases and its preparation Download PDFInfo
- Publication number
- CN1288748A CN1288748A CN 99119165 CN99119165A CN1288748A CN 1288748 A CN1288748 A CN 1288748A CN 99119165 CN99119165 CN 99119165 CN 99119165 A CN99119165 A CN 99119165A CN 1288748 A CN1288748 A CN 1288748A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- medicine
- cerebrovascular disease
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention relates to a pure Chinese medicine preparation for preventing anc curing various angiocardiopathy and cerebrovascular diseases. It is made up by using 47 Chinese medicinal materials of bovine bezoar, musk, carthamus flower, peach kernel, salvia root, ligusticum root, red peony root and ginseng, etc., and can be made into various dosage forms, such as capsule, etc., and its prescription is unique and therpeutic effect is obvious.
Description
The present invention relates to a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, specifically a kind of is the pure Chinese medicinal preparation of the treatment cardiovascular and cerebrovascular disease made of raw material with the natural Chinese medicinal herb, the invention still further relates to the preparation method of this medicine.
Cardio-cerebralvascular diseases is a kind of common multiple disease.The root that causes cardiovascular and cerebrovascular disease is: western medicine is thought hyperlipidemia, hypertension, atherosclerosis can make vessel wall thickening, and luminal stenosis is added the blood viscosity height, and platelet aggregation degree of adhering to increases.Like this week and reciprocally accelerated the formation of thrombosis, increased the weight of atherosclerosis.
Chinese medicine is thought: two big toxin are arranged in the human body.The one, in the human body intestinal canal " stool ", the 2nd, " stagnated blood " in the blood.Stool is an enterogenous endotoxin, and stagnated blood is the blood endotoxin.These two kinds of basic reasons that toxin is a cardiovascular and cerebrovascular disease.The cardiovascular and cerebrovascular disease pathogenic factor comprises: exopathogenic factor: wind, cold, summer-heat, wet, dry, fiery, epidemic disease is malicious.Endogenous cause of ill: 1. happiness, anger, melancholy, think of, compassion, probably, frightened.
2. environment: (1) external environment condition, chemical substance, air, contaminated water source.(2) internal medium: house hold affairs, social factor.
3. drug dependence is as children's's augmentin etc.
4. diet is unreasonable, includes the three-hypers material in and crosses Sheng, excessive drinking, smoking etc.
5. grain, the pesticide on the vegetable etc. is remaining, is the principal element of cardiovascular and cerebrovascular disease morbidity.
Cardiovascular and cerebrovascular disease mainly comprises: diseases such as hyperlipidemia, hypertension, heart disease, hemiplegia and epilepsy.
The medicine major defect of the above-mentioned disease of present existing treatment is as follows:
Most of depressor all is by regulating nerve, suppress adrenaline secretion, expand blood vessel etc., playing
The effect of temporary transient blood pressure lowering.And to the disadvantage factor in unnecessary unnecessary material or the body tissue in the blood
Can not in time get rid of, so can only play temporary transient effect.
Can treat the medicine of cerebral hemorrhage at present, can not treat cerebral embolism, and can treat the medicine of cerebral thrombosis plug
Thing can not be treated cerebral hemorrhage again.
Heart disease is divided pulmonary heart disease, rheumatic heart disease, coronary artery type heart disease, two or two lobe lockings at present
Polytype such as holotype heart disease not.The existing mode of curing the disease all is by heart tonifying, coronary artery dilator
Etc. temporary transient symptomatic treatment mode, can only play mitigation.
Existing various form of Chinese drug all exists variety of issue, and is big as dosage, and effective ingredient can not full use, takes inconvenience etc.Chemical purification method and utilize the efficacy of a drug single, the chemical constitution of some medicine is destroyed, and unknown composition is not suggested, and is difficult to represent the medical material overall picture.
The object of the present invention is to provide a kind of pure Chinese medicinal preparation for the treatment of various types of cardiovascular and cerebrovascular disease, scalable bodily fuctions, promoting blood circulation to remove obstruction in the collateral, promoting tissue regeneration by removing blood stasis, removing heat-phlegm, cephalocathartic are calmed the nerves, peace and the five internal organs, fortune intestinal removing food stagnancy, interior accent seven emotions, drive six climate exopathogens outward, can reach prevention and effect a radical cure the effect of all kinds of heart and brain diseases.Directly, take effect fast, treat wide spectrum, act on lastingly, have no side effect at the cause of disease.
Another object of the present invention provides the preparation method of this cardiovascular and cerebrovascular vessel Remedies for diseases in association.This preparation method can be utilized the effective elements of the medicine of respectively distinguishing the flavor of fully and effectively, has both dwindled the medication volume, has improved drug effect again.
Solution of the present invention is according to secret prescription handed down in the family from generation to generation, clinical experience through two more than ten years, learn wildly from other's strong points, select the essence, based on pathogenetic understanding and the Therapeutic Principle of motherland's medical science to cardiovascular and cerebrovascular disease, with reference to the modern pharmacological research achievement, from motherland's medical treasure-house, filter out promoting blood circulation to remove obstruction in the collateral, promoting tissue regeneration by removing blood stasis, removing heat-phlegm, heart tonifying and brain strengthening, peace and the five internal organs, fortune intestinal removing food stagnancy, the natural drug of expelling wind and removing dampness is according to the theory of Chinese medical science prescription.Each medicine synergism of distinguishing the flavor of is to reach curative effect.
The present invention treats the medicine of cardiovascular and cerebrovascular vessel and is made by following component: (consumption is a weight portion)
Calculus Bovis 4-8 Moschus 4-8 Flos Carthami 80-120
Semen Persicae 30-90 Radix Salviae Miltiorrhizae 80-130 Rhizoma Chuanxiong 80-130
Radix Paeoniae Rubra 40-80 ginseng 80-130 Rhizoma Acori Graminei 30-70
Radix Polygalae 30-70 Arisaema Cum Bile 35-70 Bulbus Allii Macrostemonis 80-120
Rhizoma Atractylodis Macrocephalae 50-80 Poria 50-90 Fructus Crotonis 20-50
Radix Et Rhizoma Rhei 80-120 Rhizoma Alismatis 80-120 Herba Cistanches 80-120
Radix Angelicae Sinensis 80-130 Radix Astragali 80-130 Rhizoma Corydalis 30-80
Radix Notoginseng 80-120 Hirudo 900-1700 Tabanus 120-160
Sanguis Draxonis 80-120 Radix Curcumae 40-70 Rhizoma Gastrodiae 90-110
Succinum 130-160 Cinnabaris 130-160 Styrax 130-160
Borneolum Syntheticum 90-110 Aspongopus 90-100 Colla cornus cervi 140-160
Zaocys 90-120 Agkistrodon 25-35 Ganoderma 90-120
Placenta Hominis powder 140-170 Lignum Santali Albi 40-70 Radix Aucklandiae 30-55
Rhizoma Pinelliae 30-55 Rhizoma Coptidis 90-120 Margarita powder 90-120
Cornu Cervi Pantotrichum 35-60 Scolopendra 90-130 Scorpio 90-160
Carapax et Plastrum Testudinis 30-70 Squama Manis 30-75 prepares formula optimization weight of the present invention (part) ratio range:
Calculus Bovis 4 Moschus 4 Flos Carthamis 100
Semen Persicae 50 Radix Salviae Miltiorrhizaes 100 Rhizoma Chuanxiongs 100
Radix Paeoniae Rubra 60 Radix Ginseng Rubra 100 Rhizoma Acori Gramineis 50
Radix Polygalae 50 Arisaema Cum Bile 50 Bulbus Allii Macrostemonis 100
The Rhizoma Atractylodis Macrocephalae 70 Poria 70 Fructus Crotonis 30
Radix Et Rhizoma Rhei 100 Rhizoma Alismatis 100 Herba Cistanches 100
Radix Angelicae Sinensis 100 Radixs Astragali 100 Rhizoma Corydalis 50
Radix Notoginseng 100 Hirudos 1500 Tabanuss 150
Sanguis Draxonis 100 Radix Curcumaes 60 Rhizoma Gastrodiaes 100
Succinum 150 Cinnabaris 150 Styrax 150
Borneolum Syntheticum 100 Aspongopuss 100 Colla cornus cervis 150
Zaocys 100 Agkistrodons 30 Ganodermas 100
Placenta Hominis powder 150 Lignum Santali Albis 60 Radix Aucklandiae 50
The Rhizoma Pinelliae 50 Rhizoma Coptidis 100 Margarita powder 100
Cornu Cervi Pantotrichum 50 Scolopendras 100 Scorpio 100
Carapax et Plastrum Testudinis 50 Squama Maniss 50
Each flavor of medicine of the present invention is crude drug, starts with from the cause of disease of cardiovascular and cerebrovascular disease, according to cause of disease medication, regulates the bodily fuctions, and promoting blood circulation to remove obstruction in the collateral, promoting tissue regeneration by removing blood stasis are arranged, and interior accent seven emotions, drives the effect of six climate exopathogens outward.With the disease-relieving and physique enhancing is purpose, improves body circulation mediation microcirculation, utilizes metabolic pathway, from two just sweat gland excrete, remove body inner product reservation or revocation material, alleviate internal organs load resistance, the recovery organization normal function, safeguard the intravital ecological balance of people, eradicate source of disease, cure cardiovascular and cerebrovascular disease.
Symptoms such as medicine of the present invention also can prevent cardiovascular and cerebrovascular disease, and is dizzy if headache is arranged, nervous, taking medicine one gets final product for twice.
The present invention can make various dosage forms according to a conventional method.
Preferred a kind of capsule formulation of making by special process in various dosage forms, preparation method is as follows:
Take by weighing the crude drug of respectively distinguishing the flavor of by prescription, dry, pulverize, sieve.After residual medicine dreg decocted with water, filters filtrate is concentrated the back and add medicated powder, spread medicine out drying after stirring, incapsulate after the pulverizing and get final product.
Utilize the medicament of preparation method preparation of the present invention, be different from other traditional dosage form.Big as pharmaceutical quantities such as decoction, effective ingredient can not be all fried next, and the medical material waste is serious; Honeyed pill need adopt excipient over half during preparation, if dose is little, and efficacy of a drug deficiency, dose is big, then is difficult to swallow; Watered pill powder also is the same: the medicinal residues waste material is all taken, and measures can not reach therapeutic effect for a short time; Chemical purification utilizes the efficacy of a drug single, and some composition chemical constitution is destroyed, and unknown composition is not suggested, and is difficult to represent the medical material overall picture, just can not embody the principle that treatment by Chinese herbs cooperatively interacts and coordinates.Capsule preparations method of the present invention is got the length of each dosage form, grows its deficiency again, has both improved the utilization rate of medical material, dwindled volume again, per 5 balls adopt the capsule preparations (every ball 0.5 gram) of the medicament of the present invention of formulation method one-tenth of the present invention to be equivalent to the potion decoction, or pill material 6 grams, the efficacy of a drug of powder 10 grams.So taking convenience, it is quick to take effect, and effect is lasting, has no side effect.
For showing the therapeutic effect of medicine of the present invention to cardiovascular and cerebrovascular disease, systematically selected all ages and classes, sex and dissimilar cardiovascular and cerebrovascular disease cases comprise hypertension, hyperlipidemia, apoplexy sequela etc., its symptom is respectively:
Hypertension: diastolic pressure surpasses 90mmHg;
Hyperlipidemia: cholesterol level surpasses 5.7mmol/L in the blood, and three fat content surpass 1.7mmol/L, high-density protein, and the man is lower than 1.5mmol/L, and the woman is lower than 2.00mmol/L (in 1991 version of national Clinical Laboratory rule of operation);
Coronary heart disease: mainly according to clinical symptoms, the various performances of acute or chronic myocardial ischemia, as uncomfortable in chest, the pareordia paroxysmal pain, die Blausucht, fidgety frequently etc., and the relevant therewith age, hypertension, hyperlipidemia and ECG T wave are inverted, auxiliary examinations such as Q, R, S brownout;
The apoplexy sequela: mainly according to the morbidity history, the side limb is dumb or attach undue importance to one thing to the neglect of the other, and relevant CT Doppler, the blood fat chemical examination measure wait check unusual etc.;
In the case according to above symptom selection, male 112 people, women 88 people, maximum 82 years old age, minimal ages 18 years old, 48 years old mean age.
Use this to send out medicine preceding and treat, be 30 days a course of treatment.
Instructions of taking: each 5 balls (every ball 0.5 gram), every day three times.Treatment cycle is three courses of treatment.Shown in the curative effect statistical standard table 1, curative effect clinical data statistics is as shown in table 2.
Table 1 curative effect statistical standard
| Produce effects | The moon imitates | Invalid | |
| Hypertension | Subjective symptoms disappears, functional rehabilitation is normal, check that low pressure is below 90mmHg below the high pressure 130mmHg.Drug withdrawal several months or do not see the recidivist more than 1 year; | High drops is more than 103 kPas, and reaches normal range; Though low pressure is not reduced to normally, descended more than 2.6 kPas; | Do not reach effective standard. |
| Hyperlipidemia | Subjective symptoms disappears, cholesterol level is between 2.8-5.7 (mmol/L) in the blood, three fat content are between 0.23-1.24mmol/L, high-density protein reaches between the normal value 1.3-1.5mmol/L, and drug withdrawal was not seen the recidivist more than 1 year; | Subjective symptoms alleviates, cholesterol level is between 5.7-6.4mmol/L in the blood, three fat content are between 1.7-2.1mmol/L, and high-density protein is between 1.53-2.00mmol/L. | Do not reach effective standard. |
| Coronary heart disease | Clinical symptom disappearance, electrocardiogram premature beat disappears, and drug withdrawal is not seen recurrence more than half a year; | Clinical symptoms disappears substantially, electrocardiogram premature beat is transferred to accidental by pilosity, reduce more than 80% before the treatment; | Clinical symptoms does not have and is clearly better, and is basic identical before electrocardiogram premature beat and the treatment. |
| Apoplexy sequela | Diagnose criterion of therapeutical effect with reference to the disease of tcm that State Administration of Traditional Chinese Medicine formulated in 1994, symptom and sign disappear, and live on one's own life substantially; | Reference standard is the same, and symptom and sign take a turn for the better, can the cane action or can take care of oneself substantially; | Reference standard is the same, symptom and sign no change or deterioration person. |
Table 2 curative effect clinical data statistics
| Disease | Case load (people) | Produce effects | Effectively | Invalid | Effective percentage (%) |
| Hypertension | ????78 | ????43 | ????32 | ????3 | ????96.2 |
| Hyperlipidemia | ????65 | ????40 | ????23 | ????2 | ????96.9 |
| Coronary heart disease | ????49 | ????25 | ????23 | ????1 | ????98.0 |
| Apoplexy sequela | ????8 | ????3 | ????4 | ????1 | ????87.5 |
By above-mentioned clinical data as seen, medicine of the present invention all has a curative effect preferably for polytype cardiovascular and cerebrovascular disease, treating both the principal and secondary aspects of a disease, thoroughly remove pathogen, alleviate internal organs load resistance, the recovery organization function, thus blood circulation improved, utilize the special nature of natural plants, safeguard the intravital ecological balance of people, reach the purpose of disease-relieving and physique enhancing, by regulating and strengthen self function of patient, and disease is cured, not only can remove and alleviate the symptom of heart disease cerebrovascular faster, simultaneously can improve patient's various states preferably, reach the effect of effecting a permanent cure, stability is arranged after the treatment.Taking convenience, patient easily accepts, and side effect is little.
The length of desirable each dosage form of formulation method of the present invention is gone its deficiency again, has improved the utilization rate of medical material, dwindled again volume, taking convenience, instant effect, effect lasting, have no side effect.
Embodiment takes by weighing raw material (kilogram) by following proportioning:
Calculus Bovis 4 Moschus 4 Flos Carthamis 100
Semen Persicae 50 Radix Salviae Miltiorrhizaes 100 Rhizoma Chuanxiongs 100
Radix Paeoniae Rubra 60 Radix Ginseng Rubra 100 Rhizoma Acori Gramineis 50
Radix Polygalae 50 Arisaema Cum Bile 50 Bulbus Allii Macrostemonis 100
The Rhizoma Atractylodis Macrocephalae 70 Poria 70 Fructus Crotonis 30
Radix Et Rhizoma Rhei 100 Rhizoma Alismatis 100 Herba Cistanches 100
Radix Angelicae Sinensis 100 Radixs Astragali 100 Rhizoma Corydalis 50
Radix Notoginseng 100 Hirudos 1500 Tabanuss 150
Sanguis Draxonis 100 Radix Curcumaes 60 Rhizoma Gastrodiaes 100
Succinum 150 Cinnabaris 150 Styrax 150
Borneolum Syntheticum 100 Aspongopuss 100 Colla cornus cervis 150
Zaocys 100 Agkistrodons 30 Ganodermas 100
Placenta Hominis powder 150 Lignum Santali Albis 60 Radix Aucklandiae 50
The Rhizoma Pinelliae 50 Rhizoma Coptidis 100 Margarita powder 100
Cornu Cervi Pantotrichum 50 Scolopendras 100 Scorpio 100
Carapax et Plastrum Testudinis 50 Squama Maniss 50 preparation methoies:
Take by weighing the crude drug of respectively distinguishing the flavor of by prescription, drying is pulverized, and crosses 1200 mesh sieves, obtains the make a living medicated powder of dose about 60% of weight.Residual medicine dreg is decocted with water secondary, after the filtration filtrate is concentrated into when equating with the medicated powder volume, add medicated powder immediately, incapsulate after spreading medicine out drying and crushing after stirring, every ball is adorned 0.5 gram.Model case: 1. the high mountain towards, man, 75 years old, the high Buddhist monk's bridge of Changge town Yang Zhai people from village is in the hemiplegia that suffers stroke on November 3rd, 97, gatism, speech is unfavorable, and deviation of the mouth with numbness and paralysis is examined in No. 7, check blood pressure 180/95 millimetres of mercury, the right side hemiplegia of limb is unable, and mind is clear, stringy and rolling pulse, dimly red tongue, white and thin fur, examine and be apoplex involving the channels and collaterals (cerebral thrombosis), take Drug therapy of the present invention and obtained recovery from illness in 20 days.2. Hu Caihong, the woman, 22 years old, the silk mill worker of Changge City suffered from the facial hemiparalysis facial paralysis on February 10th, 98, took i.e. recovery from illness in 7 days behind the medicine of the present invention.3. justice is assembled, man, 102 years old, Mo He people from village, back river town, the peasant suffered from brain atrophy 2 years, and coma is not felt any better in the many places treatment, fail to see relatives, both hands vibration, poor appetite, can't take care of oneself, funeral affairs are ready, and on January 4th, 99 treated to here, recovery from illness two courses of treatment after taking this medicine, clearheaded, both hands are freely, diet increases, and defecation is normal, now can swim commentaries on classics, pulse condition is gentle, plentiful, the good springiness of the back of the hand flesh.4. Guo two girls, the woman 76 years old, lives rotating disk southern side, east, Changge City, at ordinary times the both legs numbness, send out heavy, can not walk about, look into cholesterol 2.1mmol/L, blood pressure 150/105 millimetres of mercury, a course of treatment, above symptom all disappears after taking medicine of the present invention, and it is as usual to have walked.
Claims (8)
1. medicine for the treatment of cardiovascular and cerebrovascular disease is characterized in that it is the medicament of being made by the following weight proportion raw material:
Calculus Bovis 4-8 Moschus 4-8 Flos Carthami 80-120
Semen Persicae 30-90 Radix Salviae Miltiorrhizae 80-130 Rhizoma Chuanxiong 80-130
Radix Paeoniae Rubra 40-80 Radix Ginseng Rubra 80-130 Rhizoma Acori Graminei 30-70
Radix Polygalae 30-70 Arisaema Cum Bile 35-70 Bulbus Allii Macrostemonis 80-120
Rhizoma Atractylodis Macrocephalae 50-80 Poria 50-90 Fructus Crotonis 20-50
Radix Et Rhizoma Rhei 80-120 Rhizoma Alismatis 80-120 Herba Cistanches 80-120
Radix Angelicae Sinensis 80-130 Radix Astragali 80-130 Rhizoma Corydalis 30-80
Radix Notoginseng 80-120 Hirudo 900-1700 Tabanus 120-160
Sanguis Draxonis 80-120 Radix Curcumae 40-70 Rhizoma Gastrodiae 90-110
Succinum 130-160 Cinnabaris 130-160 Styrax 130-160
Borneolum Syntheticum 90-110 Aspongopus 90-100 Colla cornus cervi 140-160
Zaocys 90-120 Agkistrodon 25-35 Ganoderma 90-120
Placenta Hominis powder 140-170 Lignum Santali Albi 40-70 Radix Aucklandiae 30-55
Rhizoma Pinelliae 30-55 Rhizoma Coptidis 90-120 Margarita powder 90-120
Cornu Cervi Pantotrichum 35-60 Scolopendra 90-130 Scorpio 90-160
Carapax et Plastrum Testudinis 30-70 Squama Manis 30-75
2. the medicine of treatment cardiovascular and cerebrovascular disease according to claim 1, wherein the weight proportion of each raw material is:
Calculus Bovis 4 Moschus 4 Flos Carthamis 100
Semen Persicae 50 Radix Salviae Miltiorrhizaes 100 Rhizoma Chuanxiongs 100
Radix Paeoniae Rubra 60 Radix Ginseng Rubra 100 Rhizoma Acori Gramineis 50
Radix Polygalae 50 Arisaema Cum Bile 50 Bulbus Allii Macrostemonis 100
The Rhizoma Atractylodis Macrocephalae 70 Poria 70 Fructus Crotonis 30
Radix Et Rhizoma Rhei 100 Rhizoma Alismatis 100 Herba Cistanches 100
Radix Angelicae Sinensis 100 Radixs Astragali 100 Rhizoma Corydalis 50
Radix Notoginseng 100 Hirudos 1500 Tabanuss 150
Sanguis Draxonis 100 Radix Curcumaes 60 Rhizoma Gastrodiaes 100
Succinum 150 Cinnabaris 150 Styrax 150
Borneolum Syntheticum 100 Aspongopuss 100 Colla cornus cervis 150
Zaocys 100 Agkistrodons 30 Ganodermas 100
Placenta Hominis powder 150 Lignum Santali Albis 60 Radix Aucklandiae 50
The Rhizoma Pinelliae 50 Rhizoma Coptidis 100 Margarita powder 100
Cornu Cervi Pantotrichum 50 Scolopendras 100 Scorpio 100
Carapax et Plastrum Testudinis 50 Squama Maniss 50
3. the medicine of treatment cardiovascular and cerebrovascular disease according to claim 1 and 2 is characterized in that said medicament is a said dosage form on any pharmaceutics.
4. the medicine of treatment cardiovascular and cerebrovascular disease according to claim 3 is characterized in that said medicament is a capsule.
5. the preparation method of the medicine of treatment cardiovascular and cerebrovascular disease according to claim 4 is characterized in that taking by weighing the crude drug of respectively distinguishing the flavor of by prescription, and is dry, pulverize, sieve; After residual medicine dreg decocted with water, filters filtrate is concentrated the back and add medicated powder, spread medicine out drying after stirring, incapsulate after the pulverizing and get final product.
6. the preparation method of the medicine of treatment cardiovascular and cerebrovascular disease according to claim 4, the medicated powder amount of the gained that it is characterized in that sieving about 60% of the dose of making a living.
7. the preparation method of the medicine of treatment cardiovascular and cerebrovascular disease according to claim 4 is characterized in that filtrate concentrated and adds medicated powder when equating as for the medicated powder volume immediately.
8. the preparation method of the medicine of treatment cardiovascular and cerebrovascular disease according to claim 4, it is characterized in that every pill capsule adorn 0.5 the gram medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99119165 CN1288748A (en) | 1999-09-17 | 1999-09-17 | Medicine for treating cardiac and cerebral vascular diseases and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99119165 CN1288748A (en) | 1999-09-17 | 1999-09-17 | Medicine for treating cardiac and cerebral vascular diseases and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1288748A true CN1288748A (en) | 2001-03-28 |
Family
ID=5280739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99119165 Pending CN1288748A (en) | 1999-09-17 | 1999-09-17 | Medicine for treating cardiac and cerebral vascular diseases and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1288748A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1314433C (en) * | 2003-07-17 | 2007-05-09 | 黑龙江省济仁药业有限公司 | Chinese traditional medicine for treating Tourette |
| CN100398139C (en) * | 2004-07-02 | 2008-07-02 | 李东林 | Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof |
| CN100430079C (en) * | 2005-01-22 | 2008-11-05 | 张明伦 | Chinese medicine for treating heart disease |
| CN100430068C (en) * | 2005-01-22 | 2008-11-05 | 张明伦 | Chinese medicine for treating cardiomyopathy |
| CN100531791C (en) * | 2007-02-06 | 2009-08-26 | 李荣昌 | Antineoplastic, anti-cancer drugs |
| CN101810333A (en) * | 2010-04-30 | 2010-08-25 | 张群法 | Health care food for preventing and treating cardiovascular and cerebrovascular diseases |
| CN101337063B (en) * | 2008-08-11 | 2010-09-29 | 李翠华 | Drop pills for treating cardiac infarction |
| CN101416991B (en) * | 2008-11-29 | 2011-01-26 | 吴红彦 | Traditional Chinese medicine preparation for treating cerebrovascular disease and preparation technique thereof |
| CN102423457A (en) * | 2011-12-08 | 2012-04-25 | 刘智中 | Guanxinshu capsules |
| CN102940680A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating cardia-cerebrovascular diseases |
| CN103099941A (en) * | 2013-03-08 | 2013-05-15 | 全成浩 | Traditional Chinese medicine oral liquid and preparation method thereof |
| CN103638275A (en) * | 2013-12-19 | 2014-03-19 | 王文兮 | Traditional Chinese medicine formula for quickly increasing flow of coronary artery and preparation method thereof |
| CN104888004A (en) * | 2015-05-29 | 2015-09-09 | 张锐 | Chinese medicinal herb granules for treating coronary heart diseases and preparation method thereof |
| CN106138532A (en) * | 2016-08-04 | 2016-11-23 | 马畅 | The inducing resuscitation for the treatment of cerebral infarction is removed obstacles Chinese medicine and preparation method thereof |
| CN110876789A (en) * | 2019-10-14 | 2020-03-13 | 巴雅超 | A Chinese medicinal composition for treating apoplexy and its sequelae, and its preparation method |
-
1999
- 1999-09-17 CN CN 99119165 patent/CN1288748A/en active Pending
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1314433C (en) * | 2003-07-17 | 2007-05-09 | 黑龙江省济仁药业有限公司 | Chinese traditional medicine for treating Tourette |
| CN100398139C (en) * | 2004-07-02 | 2008-07-02 | 李东林 | Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof |
| CN100430079C (en) * | 2005-01-22 | 2008-11-05 | 张明伦 | Chinese medicine for treating heart disease |
| CN100430068C (en) * | 2005-01-22 | 2008-11-05 | 张明伦 | Chinese medicine for treating cardiomyopathy |
| CN100531791C (en) * | 2007-02-06 | 2009-08-26 | 李荣昌 | Antineoplastic, anti-cancer drugs |
| CN101337063B (en) * | 2008-08-11 | 2010-09-29 | 李翠华 | Drop pills for treating cardiac infarction |
| CN101416991B (en) * | 2008-11-29 | 2011-01-26 | 吴红彦 | Traditional Chinese medicine preparation for treating cerebrovascular disease and preparation technique thereof |
| CN101810333A (en) * | 2010-04-30 | 2010-08-25 | 张群法 | Health care food for preventing and treating cardiovascular and cerebrovascular diseases |
| CN102423457A (en) * | 2011-12-08 | 2012-04-25 | 刘智中 | Guanxinshu capsules |
| CN102423457B (en) * | 2011-12-08 | 2013-07-24 | 刘智中 | Traditional Chinese medicine capsules for treating coronary heart disease |
| CN102940680A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating cardia-cerebrovascular diseases |
| CN102940680B (en) * | 2012-10-31 | 2014-11-26 | 成都医路康医学技术服务有限公司 | Medicine composition for treating cardia-cerebrovascular diseases |
| CN103099941A (en) * | 2013-03-08 | 2013-05-15 | 全成浩 | Traditional Chinese medicine oral liquid and preparation method thereof |
| CN103638275A (en) * | 2013-12-19 | 2014-03-19 | 王文兮 | Traditional Chinese medicine formula for quickly increasing flow of coronary artery and preparation method thereof |
| CN103638275B (en) * | 2013-12-19 | 2016-01-20 | 王文兮 | Chinese medicinal formulae of a kind of coronary flow that increases sharply and preparation method thereof |
| CN104888004A (en) * | 2015-05-29 | 2015-09-09 | 张锐 | Chinese medicinal herb granules for treating coronary heart diseases and preparation method thereof |
| CN106138532A (en) * | 2016-08-04 | 2016-11-23 | 马畅 | The inducing resuscitation for the treatment of cerebral infarction is removed obstacles Chinese medicine and preparation method thereof |
| CN110876789A (en) * | 2019-10-14 | 2020-03-13 | 巴雅超 | A Chinese medicinal composition for treating apoplexy and its sequelae, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103656238B (en) | A kind of Chinese medicine composition for the treatment of rheumatic osteopathia | |
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN1840128A (en) | Medicine for treating cardiovascular disease | |
| CN1288748A (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
| CN1112836A (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN1868535A (en) | Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method | |
| CN1486740A (en) | Chinese medicine composition for treating cancer | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN1232279C (en) | Antilipemic Chinese medicine | |
| CN104324134B (en) | One kind improves microcirculatory Chinese medicine composition and preparation method thereof | |
| CN103212044B (en) | Traditional Chinese medicine composition for treating cardiovascular diseases | |
| CN1086586C (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1111054C (en) | Medicine for treating apoplexy and its preparing process | |
| CN101130009A (en) | Proprietary Chinese medicine for treating atherosclerosis of cardio-cerebral arteria and method for preparing the same | |
| CN1238021C (en) | Medicine for treating osteoproliferation | |
| CN105311392A (en) | Traditional Chinese medicine for treating trigeminal neuralgia | |
| CN108096536A (en) | A kind of Chinese medicine composition for treating hemiplegia | |
| CN105935385A (en) | Positive energy auxiliary agent for dredging fluid in skin scraping and cupping | |
| CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
| CN103142898B (en) | Preparation method of medicine used after esophageal achalasia operation | |
| CN1309412C (en) | Medicine composition for treating AIDS and preparing method thereof | |
| CN106344680A (en) | Traditional Chinese medicinal composition with effects of expelling wind and relieving cold-aggravated arthralgia and preparation method thereof | |
| CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |